Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours

Biomaterials

Volumn 34, Issue 31, 2013, Pages 7674-7682

  Yim, Hyeona ^a   Park, Sin jung ^a   Bae, You Han ^b   Na, Kun ^a  

^a The Catholic University of Korea   (South Korea)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Cationic nanogel; Intratumoral penetration; Multidrug resistance; Necrosis; Paclitaxel

Indexed keywords

INTRATUMORAL PENETRATION; MULTIDRUG RESISTANCE; NANOGELS; NECROSIS; PACLITAXEL;

DRUG DELIVERY; NANOSTRUCTURED MATERIALS; PHARMACODYNAMICS;

TUMORS;

HYALURONIDASE; NANOPARTICLE; PACLITAXEL; POLYETHYLENEIMINE; PULLULAN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; CANCER CELL; CANCER LOCALIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; TUMOR GROWTH;

MUS;

EID: 84880943378     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.058     Document Type: Article

References (39)

1. Byrne J.D., Betancourt T., Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 2008, 60:1615-1626.
2. Singh R., Lillard J.W. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009, 86:215-223.
3. Xu Q., Liu Y., Su S., Li W., Chen C., Wu Y. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. Biomaterials 2012, 33:1627-1639.
4. Haley B., Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol 2008, 26:57-64.
5. Xu W., Siddiqui I.A., Nihal M., Pilla S., Rosenthal K., Mukhtar H., et al. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials 2013, 34:5244-5253.
6. Di Paolo A., Bocci G. Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification. Curr Oncol Rep 2007, 9:109-114.
7. Heldin C.H., Rubin K., Pietras K., Ostman A. High interstitial fluid pressure-an obstacle in cancer therapy. Nat Rev Cancer 2004, 4:806-813.
8. Denison T.A., Bae Y.H. Tumor heterogeneity and its implication to drug delivery. JControl Release 2012, 164:187-191.
9. Yim H., Na K. Polycationic nanodrug covered with hyaluronic acid for treatment of p-glycoprotein overexpressing cancer cells. Biomacromolecules 2010, 11:2387-2393.
10. Minchinton A.I., Tannock I.F. Drug penetration in solid tumours. Nat Rev Cancer 2006, 6:583-592.
11. Primeau A.J., Rendon A., Hedley D., Lilge L., Tannock I.F. The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res 2005, 11:8782-8788.
12. Goodman T.T., Olive P.L., Pun S.H. Increased nanoparticle penetration in collagenase-treated multicellular spheroids. Int J Nanomedicine 2007, 2:265-274.
13. Grantab R., Sivananthan S., Tannock I.F. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 2006, 66:1033-1039.
14. Kim B., Han G., Toley B.J., Kim C., Rotello V.M., Forbes N.S. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol 2010, 5:465-472.
15. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., D'Souza G.G. Cell transfection invitro and invivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci U S A 2003, 100:1972-1977.
16. Torchilin V.P., Rammohan R., Weissig V., Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U.S.A. 2001, 98:8786-8791.
17. Stylianopoulos T., Soteriou K., Fukumura D., Jain R.K. Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model. Ann Biomed Eng 2013, 41:68-77.
18. Kostarelos K., Emfietzoglou D., Papakostas A., Yang W.H., Ballangrud A., Sgouros G. Binding and interstitial penetration of liposomes within avascular tumor spheroids. Int J Cancer 2004, 112:713-721.
19. Xia T., Kovochich M., Liong M., Zink J.I., Nel A.E. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2008, 2:85-96.
20. Leroueil P.R., Berry S.A., Duthie K., Han G., Rotello V.M., McNerny D.Q., et al. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett 2008, 8:420-424.
21. Ding L., Chi E.Y., Chemburu S., Ji E., Schanze K.S., Lopez G.P., et al. Insight into the mechanism of antimicrobial poly(phenylene ethynylene) polyelectrolytes: interactions with phosphatidylglycerol lipid membranes. Langmuir 2009, 25:13742-13751.
22. Xi K., Tabata Y., Uno K., Yoshimoto M., Kishida T., Sokawa Y., et al. Liver targeting of interferon through pullulan conjugation. Pharm Res 1996, 13:1846-1850.
23. Na K., Bum Lee T., Park K.H., Shin E.K., Lee Y.B., Choi H.K. Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur J Pharm Sci 2003, 18:165-173.
24. Zhou J., Liu J., Cheng C.J., Patel T.R., Weller C.E., Piepmeier J.M., et al. Biodegradable poly (amine-co-ester) terpolymers for targeted gene delivery. Nat Mater 2011, 11:82-90.
25. Liu D., Pearlman E., Diaconu E., Guo K., Mori H., Haqqi T., et al. Expression of hyaluronidase by tumor cells induces angiogenesis invivo. Proc Natl Acad Sci U.S.A. 1996, 93:7832-7837.
26. Franzmann E.J., Schroeder G.L., Goodwin W.J., Weed D.T., Fisher P., Lokeshwar V.B. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer 2003, 106:438-445.
27. Kovar J.L., Johnson M.A., Volcheck W.M., Chen J., Simpson M.A. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 2006, 169:1415-1426.
28. Benitez A., Yates T.J., Lopez L.E., Cerwinka W.H., Bakkar A., Lokeshwar V.B. Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells. Cancer Res 2011, 71:4085-4095.
29. Nel A.E., Mädler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009, 8:543-557.
30. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 2008, 5:487-495.
31. Zhang L., Granick S. Interleaflet diffusion coupling when polymer adsorbs onto one sole leaflet of a supported phospholipid bilayer. Macromolecules 2007, 40:1366-1368.
32. Yaroslavov A.A., Sybachin A.V., Kesselman E., Schmidt J., Talmon Y., Rizvi S.A., et al. Liposome fusion rates depend upon the conformation of polycation catalysts. JAm Chem Soc 2011, 133:2881-2883.
33. 2 bubbles to induce transient cavitation, lysosomal rupturing, and cell necrosis. Angew Chem Int Ed Engl 2012, 124:10236-10240.
34. Zong W.X., Thompson C.B. Necrotic death as a cell fate. Genes Dev 2006, 20:1-15.
35. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005, 121:335-348.
36. Bouzin C., Feron O. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery. Drug Resist Updat 2007, 10:109-120.
37. Netti P.A., Berk D.A., Swartz M.A., Grodzinsky A.J., Jain R.K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 2000, 60:2497-2503.
38. Luqmani Y. Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract 2005, 14:35-48.
39. Shen G.J., Srivastava K.C., Saha B.C., Zeikus J.G. Physiological and enzymatic characterization of a novel pullulan-degrading thermophilic Bacillus strain 3183. Appl Microbiol Biotechnol 1990, 33:340-344.